Econ Financial Services Corp purchased a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 21,610 shares of the exchange traded fund’s stock, valued at approximately $1,946,000.
A number of other hedge funds have also recently bought and sold shares of the business. Avior Wealth Management LLC boosted its stake in shares of SPDR S&P Biotech ETF by 393.6% during the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after buying an additional 307 shares during the last quarter. Tidemark LLC boosted its stake in SPDR S&P Biotech ETF by 101.5% during the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after acquiring an additional 199 shares during the last quarter. Quintet Private Bank Europe S.A. acquired a new position in SPDR S&P Biotech ETF during the 3rd quarter worth $40,000. ORG Wealth Partners LLC bought a new stake in shares of SPDR S&P Biotech ETF in the 3rd quarter worth about $44,000. Finally, Howe & Rusling Inc. acquired a new stake in shares of SPDR S&P Biotech ETF in the 3rd quarter valued at about $49,000.
SPDR S&P Biotech ETF Stock Performance
NYSEARCA:XBI opened at $92.57 on Wednesday. The company has a market capitalization of $7.06 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a one year low of $81.14 and a one year high of $105.47. The stock has a 50-day simple moving average of $92.99 and a 200 day simple moving average of $96.59.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Recommended Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- What is the FTSE 100 index?
- Market Volatility Creates Opportunity in These 3 Value Stocks
- Options Trading – Understanding Strike Price
- Visa and Mastercard Remain Strong Plays as Consumers Keep Swiping
- Investing in the High PE Growth Stocks
- 2 High-Yield Consumer Staples Stocks Ready to Deliver Big Returns
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.